Latest Shareholder Voting News

PointsBet has released a supplementary scheme booklet revealing an improved $1.20 per share cash offer from MIXI, alongside a postponed shareholder meeting now set for June 25. The deal, backed unanimously by the PointsBet board, faces final court and regulatory approvals.

Lakes Blue Energy has raised $6.5 million through a fully underwritten placement to fund the drilling and testing of its Wombat 5 appraisal well in Victoria, positioning itself to address looming gas shortages on Australia’s east coast.

Betr Entertainment has reaffirmed its superior $1.33 per share acquisition proposal for PointsBet, challenging the rival MIXI offer ahead of a crucial shareholder vote. With strong funding and synergy claims, Betr signals confidence that MIXI’s $1.20 bid will be rejected.

Patrys Limited has formalized the redundancy of CEO Dr James Campbell, with a $535,877 payout partly converted into shares pending shareholder approval. Dr Campbell will continue as a non-executive director.

Clean Seas Seafood updates shareholders on a lower scrip alternative ratio following Yumbah Aquaculture’s significant asset impairments, while the scheme meeting is postponed to early July.

Astron Corporation is set to redomicile from Hong Kong to Australia, establishing a new Australian parent company and simplifying shareholder engagement. This move aims to align governance with local standards and boost investor confidence.

PointsBet’s board has unanimously dismissed Betr Entertainment’s acquisition proposal, reaffirming that MIXI Australia’s $1.20 per share cash offer remains the superior path forward for shareholders.

PointsBet Holdings has formalised a conditional takeover bid deed with MIXI at $1.20 per share, activating if shareholders reject the current scheme of arrangement. The deal hinges on key regulatory approvals and a minimum 50.1% acceptance threshold.

Harvest Technology Group’s CEO, Ilario Faenza, has stepped in with a $500,000 unsecured loan to support the company’s working capital, highlighting ongoing liquidity management efforts.

Mayne Pharma rejects Cosette Pharmaceuticals’ claims of valid termination of their scheme deal, setting the stage for a September court showdown while urging shareholders to back the scheme in June.

Santos Limited has received a compelling non-binding proposal from the XRG Consortium to acquire the company at a significant premium, prompting the board to engage in due diligence and negotiations. This move could reshape the Australian energy landscape if finalized.

Mayne Pharma has dismissed a fresh termination notice from Cosette Pharmaceuticals, reaffirming its commitment to proceed with the upcoming Scheme Meeting on 18 June 2025. The dispute centers on the validity of the Scheme Implementation Deed termination claims.